CCL Pharmaceuticals expands manufacturing footprint with the acquisition of a PIC/S Approved Plant

CCL Pharmaceuticals expands manufacturing footprint with the acquisition of a PIC/S Approved Plant
CCL is pleased to announce the acquisition of a PIC/S approved plant in the Sundar Industrial Estate, Lahore. This marks a significant stride in our commitment to growth and innovation, improving access to medicines, and reinforcing our mission of enabling a Healthy Happy Life. The state-of-the-art manufacturing plant showcases our industry expertise and commitment to advancing pharmaceutical solutions. This acquisition will contribute positively to the economy, create employment opportunities, and enable CCL to enhance its global footprint. Our leadership team officially took over the plant and engaged with the employees reinforcing our commitment to our vision, values, and culture. This milestone is a testament to our journey of making a meaningful impact on healthcare and society.
Related Posts